CAS 1584647-27-7

(2R,3S)-N1-[(3S)-5-(3-Fluorophenyl)-2,3-dihydro-9-methyl-2-oxo-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide

CAS: 1584647-27-7

(2R,3S)-N1-[(3S)-5-(3-Fluorophenyl)-2,3-dihydro-9-methyl-2-oxo-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide

Fórmula: C₂₆H₂₅F₇N₄O₃

Pureza: 99.81%

Peso molecular: 574.49

Ref: 54-PC1029051

(2R,3S)-N1-[(3S)-5-(3-Fluorophenyl)-2,3-dihydro-9-methyl-2-oxo-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide

CAS: 1584647-27-7

Pureza: 99.81%

Ref: IN-DA00HYHR

BMS 986115

Produto Controlado

CAS: 1584647-27-7

BMS 986115 is a secretase inhibitor that inhibits the amyloid-β (Aβ) pathway, which may be responsible for the development of Alzheimer's disease. BMS 986115 has been shown to have anti-cancer effects in preclinical models, blocking constitutive activation of β-catenin and suppressing tumour growth. In addition, BMS 986115 has been shown to be effective against solid tumours and life-threatening desmoid tumours. It has also been shown to be well tolerated with minimal toxicity in preclinical models.

Fórmula: C₂₆H₂₅F₇N₄O₃

Pureza: Min. 95%

Peso molecular: 574.5 g/mol

Ref: 3D-JNC64727

Notch inhibitor 1

CAS: 1584647-27-7

Notch inhibitor 1 blocks Notch 1/3 (IC50: 7.8/8.5 nM) and aids cancer research.

Fórmula: C₂₆H₂₅F₇N₄O₃

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 574.49

Ref: TM-T16341